Background: Lung cancer remains a significant health concern, and the effectiveness of early detection significantly enhances patient survival rates. Identifying lung tumors with high precision is a challenge due to the complex nature of tumor structures and the surrounding lung tissues. Methods: To address these hurdles, this paper presents an innovative three-step approach that leverages Generative Adversarial Networks (GAN), Long Short-Term Memory (LSTM), and VGG16 algorithms for the accurate reconstruction of three-dimensional (3D) lung tumor images. The first challenge we address is the accurate segmentation of lung tissues from CT images, a task complicated by the overwhelming presence of non-lung pixels, which can lead to classifier imbalance. Our solution employs a GAN model trained with a reinforcement learning (RL)-based algorithm to mitigate this imbalance and enhance segmentation accuracy. The second challenge involves precisely detecting tumors within the segmented lung regions. We introduce a second GAN model with a novel loss function that significantly improves tumor detection accuracy. Following successful segmentation and tumor detection, the VGG16 algorithm is utilized for feature extraction, preparing the data for the final 3D reconstruction. These features are then processed through an LSTM network and converted into a format suitable for the reconstructive GAN. This GAN, equipped with dilated convolution layers in its discriminator, captures extensive contextual information, enabling the accurate reconstruction of the tumor’s 3D structure. Results: The effectiveness of our method is demonstrated through rigorous evaluation against established techniques using the LIDC-IDRI dataset and standard performance metrics, showcasing its superior performance and potential for enhancing early lung cancer detection. Conclusions:This study highlights the benefits of combining GANs, LSTM, and VGG16 into a unified framework. This approach significantly improves the accuracy of detecting and reconstructing lung tumors, promising to enhance diagnostic methods and patient results in lung cancer treatment.
